Dr Ghazi Kayali
Dr Kayali is the CEO of Human Link, a Lebanese NGO that he helped establish in 2014. His research focuses on emerging viruses at the human-animal interface with emphasis on influenza and coronaviruses. He runs surveillance projects in several countries in the Middle East and Africa collecting samples from animal and exposed human populations. He is also a regional consultant for preparedness and response, zoonoses, pandemic influenza, and International Health Regulations.
Novel Coronavirus (2019-nCoV): Where are we now, and where should we be going?
"As I write these lines, the novel coronavirus epidemic that started in Wuhan, China on December 8, 2019, has infected more people than the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome coronavirus (MERS-CoV) combined." In this Blog, written by Dr Ghazi Kayali, a member of BMC Infectious Diseases Editorial Board, we discuss the rise of the novel 2019 Coronavirus and its significant public health implications.
As of the 3rd February 2020 17,489 cases have been confirmed in China and 24 other countries, of which, 362 patients have died. This has sparked an overwhelming response by the Chinese government placing more than 60 million people under orders of restricted movement, mandated wearing of masks in public (at the threat of arrest), and increase of their healthcare capacity by, for example, construction of a 1200-bed hospital in just 10 days. The epidemic rages on with an average of 2000 new cases reported daily.
.png)
No hay comentarios:
Publicar un comentario